The latest biotech news

News and Trends 2 Mar 2018

London Biotech Uses Unique Double Mechanism of Action to Treat Cystic Fibrosis

Verona Pharma obtained positive Phase IIa trial results for a unique cystic fibrosis drug that inhibits two disease-related enzymes simultaneously, showing promise for treating a high unmet patient need. Verona Pharma, based in London, UK, aims to improve the lives of people with chronic respiratory diseases. Verona states their Phase IIa data provide grounds to […]

March 2, 2018 - 2 minutesmins - By Alexander Burik

News and Trends 1 Mar 2018

Biosensors Bring HIV Test to Patients for Instant Results

A report on the use of biosensors in molecular disease diagnostics states the technology could significantly reduce the spread of HIV. A report by Cambridge-based IDTechEx analyzed important trends in the field of medical biosensors. Their results suggest the technology could reduce the spread of HIV and sexually transmitted diseases in general by cutting the time taken to send tests to a […]

March 1, 2018 - 3 minutesmins - By Alexander Burik

News and Trends 1 Mar 2018

Doudna and Charpentier Get Second CRISPR Patent in Europe

Just a month after the European Patent Office revoked a CRISPR patent from the competitors of Doudna and Charpentier, they have been granted a second patent that covers a new form of the popular gene editing tool. The European Patent Office has granted CRISPR co-inventor Emmanuelle Charpentier, together with the University of California and the University […]

March 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 1 Mar 2018

Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?

Stimunity, a Parisian biotech, secured a 2M€ seed investment to develop a cancer treatment that could compete with that of big players such as Merck and Novartis. Stimunity is a preclinical-stage startup company which develops drugs targeting a new cell signalling pathway to treat cancer. The company secured funding from Portage, a US-Canadian firm that […]

March 1, 2018 - 3 minutesmins - By Alexander Burik

Idorsia Actelion Spin Off Jean Paul Clozel CEO

News and Trends 1 Mar 2018

How is Actelion Spin-Off Idorsia Doing One Year Later?

Actelion’s spin-off Idorsia was blessed with a large pipeline and a healthy bank balance. How has the biotech’s first year of business gone? Just over a year ago, Actelion, the largest biotech in Europe at the time, was snapped up by Johnson & Johnson for a massive €27.9Bn. “This deal is unique: J&J gets its […]

March 1, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 28 Feb 2018

Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine

Bavarian Nordic and AstraZeneca collaborate on a treatment that uses a cancer vaccine along with a checkpoint inhibitor to treat colorectal and pancreatic cancer. Notably, this is the third checkpoint inhibitor to be tested with Bavarian Nordic’s vaccine. A Phase I/II trial will evaluate the safety and efficacy of using Bavarian Nordic’s cancer vaccine CV301 in […]

February 28, 2018 - 3 minutesmins - By Alexander Burik

novo holdings antibiotic resistance fight 1

News and Trends 28 Feb 2018

Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance

Novo Holdings has launched a $165M (€135M) impact fund to support companies that are developing new drugs to overcome antibiotic resistance. Novo Holdings manages the assets of the Novo Nordisk Foundation, which invests money in companies that are working on scientific, humanitarian, and social projects. The company has launched a fund to develop new treatments for infections […]

February 28, 2018 - 3 minutesmins - By Alex Dale

News and Trends 28 Feb 2018

Now We Know How the Brain Controls Pain, Better Analgesia Should Be on the Way

Researchers at the University of Cambridge believe that they have found the region of the brain that is responsible for pain relief, which should help future drug development efforts. Scientists at the University of Cambridge have identified the area of the brain that is responsible for pain relief, which could boost the development of alternative […]

February 28, 2018 - 4 minutesmins - By Alex Dale

News and Trends 28 Feb 2018

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

Rare diseases affect fewer than 1 in 2,000 people in Europe and less than 200,000 Americans at any given time. A lack of financial incentive has put pharma off but biotechs are keen to step in and develop treatments and cures. Over 6,000 rare diseases affect up to 30 million people in the EU alone, which highlights […]

February 28, 2018 - 8 minutesmins - By Alex Dale

News and Trends 27 Feb 2018

This Small Molecule Protects the Muscles of Patients With Duchenne Muscular Dystrophy

Summit Therapeutics’ treatment for the devastating disease, Duchenne muscular dystrophy, reduces inflammation, which could protect muscle fibers from damage. Summit Therapeutics focuses on the development of treatments that can help patients suffering from diseases that currently lack options. The biotech has reported Phase II results for its drug for the genetic disease, Duchenne muscular dystrophy […]

February 27, 2018 - 3 minutesmins - By Alex Dale

News and Trends 27 Feb 2018

Update: Deinove is About to Launch a Bacterial Anti-Aging Skincare Product

Update (27/2/2018): Deinove produced the first industrial batch of its carotenoid product and plans to launch the cosmetic skincare treatment at the In-Cosmetics tradeshow in Amsterdam this coming April. The news resulted in a soaring 57% increase of Deinove’s stock price. Originally published on 19/12/2017 Deinove has set the wheels in motion as it looks […]

February 27, 2018 - 2 minutesmins - By Alex Dale

News and Trends 27 Feb 2018

Successful Phase III Results for Swiss Biotech ObsEva’s Drug for In Vitro Pregnancy

Yesterday, Swiss biotech ObsEva highlighted positive Phase III results that show their fertility treatment nolasiban improved the pregnancy rate of women following in vitro fertilization. ObsEva, a clinical stage, Geneva-based biopharmaceutical company dedicated to women’s reproductive medicine, states that current Phase III results for the drug show an increase in pregnancy rate of 32 % after […]

February 27, 2018 - 2 minutesmins - By Alexander Burik

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

News and Trends

London Biotech Uses Unique Double Mechanism of Action to Treat Cystic Fibrosis

Biosensors Bring HIV Test to Patients for Instant Results

Doudna and Charpentier Get Second CRISPR Patent in Europe

Could This Parisian Biotech Startup’s Cancer Treatment Compete With Merck and Novartis?

How is Actelion Spin-Off Idorsia Doing One Year Later?

Yet Another Checkpoint Inhibitor Goes to Trial with Bavarian Nordic’s Cancer Vaccine

Novo Holdings Pumps €135M into New Antibiotic Development to Fight Resistance

Now We Know How the Brain Controls Pain, Better Analgesia Should Be on the Way

Like Finding a Needle in a Haystack: How Are Biotechs Fighting Rare Diseases?

This Small Molecule Protects the Muscles of Patients With Duchenne Muscular Dystrophy

Update: Deinove is About to Launch a Bacterial Anti-Aging Skincare Product

Successful Phase III Results for Swiss Biotech ObsEva’s Drug for In Vitro Pregnancy

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!